- Home
- Publications
- Publication Search
- Publication Details
Title
CD44v6 engages in colorectal cancer progression
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-10
DOI
10.1038/s41419-018-1265-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2018) R Glynne-Jones et al. ANNALS OF ONCOLOGY
- Colorectal Cancer: Why Does Side Matter?
- (2018) Claire Gallois et al. DRUGS
- The biology and role of CD44 in cancer progression: therapeutic implications
- (2018) Chen Chen et al. Journal of Hematology & Oncology
- Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
- (2018) Claudia Allemani et al. LANCET
- Immunotherapy of Colon Cancer
- (2018) Alexander Stein et al. Oncology Research and Treatment
- Clinical Significance of CD44 Variants Expression in Colorectal Cancer
- (2018) Xiao-Dong Li et al. TUMORI
- MET Signaling Mediates Intestinal Crypt-Villus Development, Regeneration, and Adenoma Formation and Is Promoted by Stem Cell CD44 Isoforms
- (2017) Sander P.J. Joosten et al. GASTROENTEROLOGY
- Intramucosal colorectal carcinoma with invasion of the lamina propria: a study by the Japanese Society for Cancer of the Colon and Rectum
- (2017) Motohiro Kojima et al. HUMAN PATHOLOGY
- The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study
- (2017) Jonna Berntsson et al. INTERNATIONAL JOURNAL OF CANCER
- Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer
- (2017) Evgenia Karousou et al. MATRIX BIOLOGY
- Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance
- (2017) K A Whelan et al. ONCOGENE
- Molecular classification and precision therapy of cancer: immune checkpoint inhibitors
- (2017) Yingyan Yu Frontiers of Medicine
- What roles do colon stem cells and gap junctions play in the left and right location of origin of colorectal cancers?
- (2017) James E. Trosko et al. Journal of Cell Communication and Signaling
- ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
- (2016) E. Van Cutsem et al. ANNALS OF ONCOLOGY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies
- (2016) Min Fang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Intratumoral heterogeneity of CD44v6 in rectal cancer
- (2016) H.-G. Liu et al. Clinical & Translational Oncology
- Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference With CD44v6 Signaling
- (2016) Alexandra Matzke-Ogi et al. GASTROENTEROLOGY
- Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks inex vivoculture
- (2016) Fanny Grillet et al. GUT
- Upregulation of CD44v6 contributes to acquired chemoresistance via the modulation of autophagy in colon cancer SW480 cells
- (2016) Lin Lv et al. TUMOR BIOLOGY
- MET-Driven Resistance to Dual EGFR and BRAF Blockade May Be Overcome by Switching from EGFR to MET Inhibition in BRAF-Mutated Colorectal Cancer
- (2016) F. Pietrantonio et al. Cancer Discovery
- Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
- (2015) René Adam et al. CANCER TREATMENT REVIEWS
- Is right-sided colon cancer different to left-sided colorectal cancer? – A systematic review
- (2015) G.H. Lee et al. EJSO
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer
- (2015) Bangli Hu et al. MEDICINE
- CD44v6 promotes β-catenin and TGF-β expression, inducing aggression in ovarian cancer cells
- (2015) JING WANG et al. Molecular Medicine Reports
- The genomic landscape of response to EGFR blockade in colorectal cancer
- (2015) Andrea Bertotti et al. NATURE
- The consensus molecular subtypes of colorectal cancer
- (2015) Justin Guinney et al. NATURE MEDICINE
- Porcupine inhibitor suppresses paracrine Wnt-driven growth ofRnf43;Znrf3-mutant neoplasia
- (2015) Bon-Kyoung Koo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Different treatment strategies and molecular features between right-sided and left-sided colon cancers
- (2015) Hong Shen WORLD JOURNAL OF GASTROENTEROLOGY
- CD44v6 expression is associated with a poor prognosis in Chinese hepatocellular carcinoma patients: A meta-analysis
- (2015) Yong Fu et al. Clinics and Research in Hepatology and Gastroenterology
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer
- (2015) Fotios Loupakis et al. JNCI-Journal of the National Cancer Institute
- Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H)
- (2014) J. Goldstein et al. ANNALS OF ONCOLOGY
- Distal and proximal colon cancers differ in terms of molecular, pathological, and clinical features
- (2014) E. Missiaglia et al. ANNALS OF ONCOLOGY
- Perspectives of CD44 targeting therapies
- (2014) V. Orian-Rousseau et al. ARCHIVES OF TOXICOLOGY
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Programmed Cell Death 1 (PD-1) and Its Ligand (PD-L1) in Common Cancers and Their Correlation with Molecular Cancer Type
- (2014) Z. Gatalica et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis
- (2014) Matilde Todaro et al. Cell Stem Cell
- Colorectal Cancer Stem Cells: From the Crypt to the Clinic
- (2014) Ann Zeuner et al. Cell Stem Cell
- Regulation of alternative splicing of CD44 in cancer
- (2014) Lubomir Prochazka et al. CELLULAR SIGNALLING
- The significance of autophagy in colorectal cancer pathogenesis and implications for therapy
- (2014) K Lai et al. JOURNAL OF CLINICAL PATHOLOGY
- Co-expression of CD133, CD44v6 and human tissue factor is associated with metastasis and poor prognosis in pancreatic carcinoma
- (2014) KAI CHEN et al. ONCOLOGY REPORTS
- CD44 variant 6 is associated with prostate cancer metastasis and chemo-/radioresistance
- (2014) Jie Ni et al. PROSTATE
- Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis
- (2014) Hao Jiang et al. TUMOR BIOLOGY
- Resistance to Anti-EGFR Therapy in Colorectal Cancer: From Heterogeneity to Convergent Evolution
- (2014) S. Misale et al. Cancer Discovery
- The peculiarities of the SDF-1/CXCL12 system: in some cells, CXCR4 and CXCR7 sing solos, in others, they sing duets
- (2013) Malte Puchert et al. CELL AND TISSUE RESEARCH
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling
- (2013) J Zeilstra et al. ONCOGENE
- Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer
- (2013) Alberto Bardelli et al. Cancer Discovery
- A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers
- (2013) Russell C. Langan et al. Journal of Cancer
- FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk
- (2012) Alexandros Garouniatis et al. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
- Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD)
- (2012) Karl E. Miletti-González et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Differential expression of CD133 based on microsatellite instability status in human colorectal cancer
- (2012) Jae Jun Park et al. MOLECULAR CARCINOGENESIS
- Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells
- (2012) Jianjin Huang et al. PLoS One
- Osteopontin promotes CCL5-mesenchymal stromal cell-mediated breast cancer metastasis
- (2011) Zhiyong Mi et al. CARCINOGENESIS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Autophagy positively regulates the CD44+CD24-/lowbreast cancer stem-like phenotype
- (2011) Sílvia Cufí et al. CELL CYCLE
- Hyaluronan-CD44 interactions as potential targets for cancer therapy
- (2011) Suniti Misra et al. FEBS Journal
- Cytotoxic T lymphocyte migration and effector function in the tumor microenvironment
- (2011) Bettina Weigelin et al. IMMUNOLOGY LETTERS
- Integrating developmental signals: a Hippo in the (path)way
- (2011) A Mauviel et al. ONCOGENE
- Osteopontin Enhances the Expression and Activity of MMP-2 via the SDF-1/CXCR4 Axis in Hepatocellular Carcinoma Cell Lines
- (2011) Rihua Zhang et al. PLoS One
- CD44, a therapeutic target for metastasising tumours
- (2010) Véronique Orian-Rousseau EUROPEAN JOURNAL OF CANCER
- Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles
- (2010) Minoo INTERNATIONAL JOURNAL OF ONCOLOGY
- Proteomic identification of CD44 interacting proteins
- (2010) Spyros S. Skandalis et al. IUBMB LIFE
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Is There a Difference in Survival Between Right- Versus Left-Sided Colon Cancers?
- (2008) Robert A. Meguid et al. ANNALS OF SURGICAL ONCOLOGY
- iASPP Inhibition: Increased Options in Targeting the p53 Family for Cancer Therapy
- (2008) H. S. Bell et al. CANCER RESEARCH
- Deletion of the WNT Target and Cancer Stem Cell Marker CD44 in Apc(Min/+) Mice Attenuates Intestinal Tumorigenesis
- (2008) J. Zeilstra et al. CANCER RESEARCH
- Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression
- (2008) Samuel Godar et al. CELL
- Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
- (2008) I Zlobec et al. GUT
- The Effects of Myostatin on Adipogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells Are Mediated through Cross-communication between Smad3 and Wnt/β-Catenin Signaling Pathways
- (2008) Wen Guo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started